Pregled bibliografske jedinice broj: 1111931
Secondary use of routinely collected health data and caring for the elderly: a case study of potentially harmful prescribing
Secondary use of routinely collected health data and caring for the elderly: a case study of potentially harmful prescribing // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 142 (2020), Suppl 1 / Kujundžić Tiljak, Mirjana ; Reiner, Željko ; Klarica, Marijan ; Anić, Branimir ; Borovečki, Ana (ur.).
Zagreb: Hrvatski liječnički zbor, 2020. str. 109-109 doi:10.26800/LV-142-Suppl1-4 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 1111931 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Secondary use of routinely collected health data
and caring for the elderly: a case study
of potentially harmful prescribing
(Secondary use of routinely collected health data
and caring for the elderly: a case
study of potentially harmful prescribing)
Autori
Gvozdanović, Katarina ; Draušnik, Željka ; Gvozdanović, Darko ; Jurak, Ivan ; Fišter, Kristina
Kolaboracija
Secondary Use of Biomedical and Health Data Working Group (SEKA)
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 142 (2020), Suppl 1
/ Kujundžić Tiljak, Mirjana ; Reiner, Željko ; Klarica, Marijan ; Anić, Branimir ; Borovečki, Ana - Zagreb : Hrvatski liječnički zbor, 2020, 109-109
Skup
BHFA2020 Better future of healthy ageing 2020
Mjesto i datum
Online ; Zagreb, Hrvatska, 03.06.2020. - 05.06.2020
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
secondary health data ; CEZIH ; harmful prescribing
Sažetak
Introduction and objectives. Elderly are the largest group of users of prescription medications. Over 20 % of the population in Croatia is older than 65 years and this proportion is expected to increase as the population is ageing. Due to the multi-morbidities, multiple concomitant medicines, and underlying metabolic and cognitive changes, drug prescribing in the elderly can result in adverse health outcomes and unnecessary costs for the health system. The objective of our work is to explore the potential of secondary use of routinely collected health data for generating the evidence in support of healthy ageing, using potentially inappropriate drug prescribing as a case study. Methods. The Central Health Information System of the Republic of Croatia (CEZIH) is the largest source of routinely collected health data in Croatia. Based on the published functional specification, we analysed CEZIH in terms of its structure and available data elements. As a measure of inappropriate drug prescribing, we chose the internationally accepted STOPP/START criteria (Screening Tool of Older People’s Prescriptions and Screening Tool to Alert to Right Treatment) for prescribing in older people. We compared the data contained in CEZIH with the information needed for the implementation of the STOPP/START criteria. Results. The STOPP/START criteria provide 114 evidence based rules to avoid commonly encountered points of potentially inappropriate prescribing. The precondition to apply those rules is availability of information on patient age, prescribed medications, indications, medical conditions. ePrescription contains structured information for over 99% of medicines prescribed/ dispensed in the primary care setting since 2011. The attributes available in ePrescription include brand name, active substance, dose, form, indication, date of prescription and dispensation, patient identifier which allows for application of 38 STOPP/START criteria. Additional information can be retrieved from the electronic healthcare record within CEZIH (64 criteria). Conclusion. Routinely collected electronic patient data in Croatia can be used to generate the evidence on inappropriate drug prescribing using STOPP/ START criteria. Such analyses have been done in many countries to assess suboptimal prescribing practices, however, in Croatia, this has not been the case despite the importance of the issue. Secondary use is a complex process that requires accessible data, understanding of data sources, data structure and research methodologies. Interdisciplinary and inter-institutional collaboration is important to make the most of the results and to support regulatory actions and policy development.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita, Interdisciplinarne biotehničke znanosti
POVEZANOST RADA
Ustanove:
Hrvatski zavod za javno zdravstvo,
Ericsson Nikola Tesla d.d.,
Medicinski fakultet, Zagreb,
Zdravstveno veleučilište, Zagreb
Profili:
Katarina Gvozdanović
(autor)
Ivan Jurak
(autor)
Željka Draušnik
(autor)
Kristina Fišter
(autor)
Darko Gvozdanović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus